Differential characteristics in elderly patients with community-acquired pneumonia (CAP) who required admission to ICU

P. Catalan Serra, E. Fernandez-Fabrellas, A. Cervera Juan, J. Blanquer Olivas, C. Senent Español, F. Sanz Herrero, E. Chiner Vives, M. C. Aguar Benito (Valencia, Spain)

Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Catalan Serra, E. Fernandez-Fabrellas, A. Cervera Juan, J. Blanquer Olivas, C. Senent Español, F. Sanz Herrero, E. Chiner Vives, M. C. Aguar Benito (Valencia, Spain). Differential characteristics in elderly patients with community-acquired pneumonia (CAP) who required admission to ICU. Eur Respir J 2009; 34: Suppl. 53, 2389

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic biomarkers in severe community-acquired pneumonia (SCAP) patients, requiring intensive care unit (ICU) admission
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012


Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011



An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Predictive factors of length of hospital stay in patients admitted with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 375s
Year: 2006

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Discharge delay in patients with community-acquired pneumonia (CAP) treated with a pneumonia critical pathway
Source: Eur Respir J 2002; 20: Suppl. 38, 560s
Year: 2002

Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

Severe community-acquired pneumonia (CAP): validation of the IDSA/ATS guidelines to predict admission to the ICU
Source: Annual Congress 2008 - Diagnosis and outcome in critically ill patients
Year: 2008


Community-acquired pneumonia Fine V: clinical profile and outcomes of ICU and non-ICU patients
Source: Eur Respir J 2004; 24: Suppl. 48, 8s
Year: 2004

Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Source: Eur Respir J 2006; 27: 1210-1216
Year: 2006



Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011


Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005